Intradigm Corporation's Series B Round

Intradigm Corporation raised a round of funding on January 21, 2009.

Intradigm is a private biotechnology company focused on the discovery, development and delivery of novel targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. …

Articles about Intradigm Corporation's Series B Round: